Next Article in Journal
Zolbetuximab or Immunotherapy as the Initial Targeted Therapy in CLDN18.2-Positive, HER2-Negative Advanced Gastric Cancer: Weighing the Options
Previous Article in Journal
Serial Functional and Genomic Analyses Illuminate Clonal Evolution in Metastatic NSCLC with 12-Year Survival
 
 
Article

Article Versions Notes

Curr. Oncol. 2025, 32(11), 647; https://doi.org/10.3390/curroncol32110647
Action Date Notes Link
article pdf uploaded. 19 November 2025 15:36 CET Version of Record https://www.mdpi.com/1718-7729/32/11/647/pdf-vor
article xml file uploaded 20 November 2025 08:48 CET Original file -
article xml uploaded. 20 November 2025 08:48 CET Update https://www.mdpi.com/1718-7729/32/11/647/xml
article pdf uploaded. 20 November 2025 08:48 CET Updated version of record https://www.mdpi.com/1718-7729/32/11/647/pdf
article html file updated 20 November 2025 08:50 CET Original file https://www.mdpi.com/1718-7729/32/11/647/html
Back to TopTop